BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plaza-Zabala A, Maldonado R, Berrendero F. The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 2012;45:424-39. [PMID: 22430644 DOI: 10.1007/s12035-012-8255-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Baldo BA. Prefrontal Cortical Opioids and Dysregulated Motivation: A Network Hypothesis. Trends Neurosci 2016;39:366-77. [PMID: 27233653 DOI: 10.1016/j.tins.2016.03.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
2 Qi K, Wei C, Li Y, Sui N. Orexin receptors within the nucleus accumbens shell mediate the stress but not drug priming-induced reinstatement of morphine conditioned place preference. Front Behav Neurosci 2013;7:144. [PMID: 24133421 DOI: 10.3389/fnbeh.2013.00144] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
3 Yaeger JD, Krupp KT, Gale JJ, Summers CH. Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery 2020;8:100059. [DOI: 10.1016/j.medidd.2020.100059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Flores Á, Julià-Hernández M, Maldonado R, Berrendero F. Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol. Br J Pharmacol 2016;173:1381-92. [PMID: 26799708 DOI: 10.1111/bph.13440] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
5 Carvajal F, Alcaraz-iborra M, Lerma-cabrera JM, Valor LM, de la Fuente L, Sanchez-amate MDC, Cubero I. Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence. Behavioural Brain Research 2015;287:230-7. [DOI: 10.1016/j.bbr.2015.03.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
6 Greenwald MK. Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework. Neurobiol Stress 2018;9:84-104. [PMID: 30238023 DOI: 10.1016/j.ynstr.2018.08.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
7 Harmey D, Griffin PR, Kenny PJ. Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. Nicotine Tob Res 2012;14:1300-18. [PMID: 23024249 DOI: 10.1093/ntr/nts201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
8 Flores Á, Saravia R, Maldonado R, Berrendero F. Orexins and fear: implications for the treatment of anxiety disorders. Trends in Neurosciences 2015;38:550-9. [DOI: 10.1016/j.tins.2015.06.005] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 8.1] [Reference Citation Analysis]
9 Plaza-Zabala A, Flores Á, Martín-García E, Saravia R, Maldonado R, Berrendero F. A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior. Neuropsychopharmacology 2013;38:1724-36. [PMID: 23518606 DOI: 10.1038/npp.2013.72] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
10 Plaza-Zabala A, Li X, Milovanovic M, Loweth JA, Maldonado R, Berrendero F, Wolf ME. An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure. Neurosci Lett 2013;557 Pt B:101-6. [PMID: 24262606 DOI: 10.1016/j.neulet.2013.10.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
11 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kim HJJ, Zagzoog A, Smolyakova AM, Ezeaka UC, Benko MJ, Holt T, Laprairie RB. In vivo Evidence for Brain Region-Specific Molecular Interactions Between Cannabinoid and Orexin Receptors. Front Neurosci 2021;15:790546. [PMID: 34992518 DOI: 10.3389/fnins.2021.790546] [Reference Citation Analysis]
13 Alijanpour S, Tirgar F, Zarrindast MR. Role of dorsal hippocampal orexin-1 receptors in memory restoration induced by morphine sensitization phenomenon. Neuroscience 2016;312:215-26. [PMID: 26592714 DOI: 10.1016/j.neuroscience.2015.11.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
14 Brodnik ZD, Alonso IP, Xu W, Zhang Y, Kortagere S, España RA. Hypocretin receptor 1 involvement in cocaine-associated behavior: Therapeutic potential and novel mechanistic insights. Brain Res 2020;1731:145894. [PMID: 30071195 DOI: 10.1016/j.brainres.2018.07.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
15 Chen WY, Kao CF, Chen PY, Lin SK, Huang MC. Orexin-A level elevation in recently abstinent male methamphetamine abusers. Psychiatry Res 2016;239:9-11. [PMID: 27137956 DOI: 10.1016/j.psychres.2016.02.059] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
16 Moorman DE, James MH, Kilroy EA, Aston-Jones G. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats. Brain Res 2017;1654:34-42. [PMID: 27771284 DOI: 10.1016/j.brainres.2016.10.018] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 8.5] [Reference Citation Analysis]
17 Tung LW, Lu GL, Lee YH, Yu L, Lee HJ, Leishman E, Bradshaw H, Hwang LL, Hung MS, Mackie K, Zimmer A, Chiou LC. Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons. Nat Commun 2016;7:12199. [PMID: 27448020 DOI: 10.1038/ncomms12199] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]
18 Chakravorty S, Hanlon AL, Kuna ST, Ross RJ, Kampman KM, Witte LM, Perlis ML, Oslin DW. The Effects of Quetiapine on Sleep in Recovering Alcohol-Dependent Subjects: A Pilot Study. Journal of Clinical Psychopharmacology 2014;34:350-4. [DOI: 10.1097/jcp.0000000000000130] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
19 Brodnik ZD, Bernstein DL, Prince CD, España RA. Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep. Behav Brain Res 2015;291:377-84. [PMID: 26049058 DOI: 10.1016/j.bbr.2015.05.051] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
20 Carboni L, Ponzoni L, Braida D, Sala M, Gotti C, Zoli M. Altered mRNA Levels of Stress-Related Peptides in Mouse Hippocampus and Caudate-Putamen in Withdrawal after Long-Term Intermittent Exposure to Tobacco Smoke or Electronic Cigarette Vapour. Int J Mol Sci 2021;22:E599. [PMID: 33435320 DOI: 10.3390/ijms22020599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Horn WT, Akerman SC, Sateia MJ. Sleep in Schizophrenia and Substance Use Disorders: A Review of the Literature. Journal of Dual Diagnosis 2013;9:228-38. [DOI: 10.1080/15504263.2013.806088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Linehan V, Fang LZ, Parsons MP, Hirasawa M. High-fat diet induces time-dependent synaptic plasticity of the lateral hypothalamus. Mol Metab 2020;36:100977. [PMID: 32277924 DOI: 10.1016/j.molmet.2020.100977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Jackson KJ, Muldoon PP, De Biasi M, Damaj MI. New mechanisms and perspectives in nicotine withdrawal. Neuropharmacology 2015;96:223-34. [PMID: 25433149 DOI: 10.1016/j.neuropharm.2014.11.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
24 Selleck RA, Baldo BA. Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens. Psychopharmacology (Berl) 2017;234:1439-49. [PMID: 28054099 DOI: 10.1007/s00213-016-4522-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
25 Thompson JB, Conrad SE, Peterman JL, Papini MR. Reinforcing properties of alcohol in rats: Progressive ratio licking performance reinforced with 66% alcohol. Physiol Behav 2021;235:113393. [PMID: 33757779 DOI: 10.1016/j.physbeh.2021.113393] [Reference Citation Analysis]
26 Berrendero F, Flores Á, Robledo P. When orexins meet cannabinoids: Bidirectional functional interactions. Biochemical Pharmacology 2018;157:43-50. [DOI: 10.1016/j.bcp.2018.08.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Daiwile AP, Jayanthi S, Ladenheim B, McCoy MT, Brannock C, Schroeder J, Cadet JL. Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking. Int J Neuropsychopharmacol 2019;22:710-23. [PMID: 31562746 DOI: 10.1093/ijnp/pyz050] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
28 Flores Á, Maldonado R, Berrendero F. The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward. Biol Psychiatry 2014;75:499-507. [PMID: 23896204 DOI: 10.1016/j.biopsych.2013.06.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
29 Hunt NJ, Waters KA, Machaalani R. Promotion of the Unfolding Protein Response in Orexin/Dynorphin Neurons in Sudden Infant Death Syndrome (SIDS): Elevated pPERK and ATF4 Expression. Mol Neurobiol 2017;54:7171-85. [PMID: 27796753 DOI: 10.1007/s12035-016-0234-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
30 Suchting R, Yoon JH, Miguel GGS, Green CE, Weaver MF, Vincent JN, Fries GR, Schmitz JM, Lane SD. Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder. Brain Res 2020;1731:146359. [PMID: 31374218 DOI: 10.1016/j.brainres.2019.146359] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
31 Zhang R, Miao Q, Wang C, Zhao R, Li W, Haile CN, Hao W, Zhang XY. Genome-wide DNA methylation analysis in alcohol dependence. Addict Biol. 2013;18:392-403. [PMID: 23387924 DOI: 10.1111/adb.12037] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 7.8] [Reference Citation Analysis]
32 Flores A, Maldonado R, Berrendero F. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci 2013;7:256. [PMID: 24391536 DOI: 10.3389/fnins.2013.00256] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
33 Fattore L, Diana M. Drug addiction: An affective-cognitive disorder in need of a cure. Neuroscience & Biobehavioral Reviews 2016;65:341-61. [DOI: 10.1016/j.neubiorev.2016.04.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
34 Jennum P, Ibsen R, Knudsen S, Kjellberg J. Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study. Sleep 2013;36:835-40. [PMID: 23729926 DOI: 10.5665/sleep.2706] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 9.0] [Reference Citation Analysis]